Tixagevimab (AZD8895) is a humanized monoclonal antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It works by binding to the RBD and S protein domain, blocking the interaction with receptors.
Purity:
95.00%
CAS Number:
[2420564-02-7]
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted